Lyra Health vs Labcorp

Side-by-side comparison of AI visibility scores, market position, and capabilities

Labcorp leads in AI visibility (79 vs 58)
Lyra Health logo

Lyra Health

ChallengerHealthcare Tech

Mental Health Benefits & Digital Therapeutics

Leading mental health benefits platform for employers. Founded 2015 by ex-Facebook CFO. $5.58B valuation, $915M total funding. Serves 20M+ people through employer contracts.

AI VisibilityBeta
Overall Score
C58
Category Rank
#144 of 596
AI Consensus
71%
Trend
stable
Per Platform
ChatGPT
52
Perplexity
53
Gemini
56

About

Lyra Health is a workforce mental health platform founded in 2015 by David Ebersman (former CFO of Facebook/Meta) and Dena Bravata, headquartered in Burlingame, California. It provides AI-powered mental health benefits to employers through therapy, coaching, preventive care, specialized programs (substance use, DBT), and the Empower AI platform for personalized support.

Full profile
Labcorp logo

Labcorp

LeaderHealthcare Tech

Enterprise

Burlington NC clinical laboratory services (NYSE: LH) ~$13.1B FY2024 revenue; Fortrea CRO spun off 2023, 2000+ PSC network, specialty oncology molecular testing competing with Quest Diagnostics.

AI VisibilityBeta
Overall Score
B79
Category Rank
#31 of 596
AI Consensus
68%
Trend
stable
Per Platform
ChatGPT
74
Perplexity
82
Gemini
73

About

Laboratory Corporation of America Holdings (Labcorp) is a Burlington, North Carolina-based clinical laboratory and life sciences company — publicly traded on the New York Stock Exchange (NYSE: LH) as an S&P 500 Health Care component — providing diagnostic laboratory testing services for physicians, hospitals, health systems, and patients across the United States and internationally, and providing drug development laboratory services (biopharmaceutical clinical trial laboratory support) through approximately 60,000 employees. In fiscal year 2024, Labcorp reported revenues of approximately $13.1 billion from the Diagnostics segment — following the June 2023 separation of its Drug Development segment as Fortrea Holdings (NASDAQ: FTRE), an independent public company providing CRO (contract research organization) services to pharmaceutical and biotech clients. CEO Adam Schechter has focused the post-Fortrea Labcorp on the pure-play diagnostics business: clinical testing across 6,000+ test menu items (routine blood work, specialty genetic testing, toxicology, and anatomic pathology) processed at Labcorp's 2,000+ patient service centers and sent to regional and specialty reference laboratories for results reporting to ordering physicians. The Labcorp consumer-direct testing initiative (at-home specimen collection kits for STI testing, COVID testing, and other direct-to-consumer tests ordered at labcorp.com without physician referral) expands beyond the traditional physician-ordered testing model to capture the growing consumer health testing market. Labcorp's specialty testing portfolio (oncology genomic profiling, rare disease genetic panels, prenatal cell-free DNA testing, advanced cardiac biomarker panels) generates higher revenue per requisition than routine chemistry and hematology panels — driving mix shift toward specialty and molecular testing revenue.

Full profile

AI Visibility Head-to-Head

58
Overall Score
79
#144
Category Rank
#31
71
AI Consensus
68
stable
Trend
stable
52
ChatGPT
74
53
Perplexity
82
56
Gemini
73
57
Claude
85
64
Grok
75

Key Details

Category
Mental Health Benefits & Digital Therapeutics
Enterprise
Tier
Challenger
Leader
Entity Type
brand
company

Capabilities & Ecosystem

Capabilities

Only Lyra Health
Mental Health Benefits & Digital Therapeutics

Integrations

Only Lyra Health
Only Labcorp
Labcorp is classified as company.

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.